NCT06717126
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06717126
Title A Randomised Phase II Study of Roginolisib in Patients with Advanced/metastatic Uveal Melanoma (OCULE-01)
Acronym OCULE-01
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors iOnctura
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | GBR | ESP


No variant requirements are available.